Wugen
PrivateLast Round
Early Funding
Aug 27, 2025
Total Funding Raised
$323M
Company Overview
Wugen is a biotechnology company focused on developing innovative CAR-T and memory NK cell therapies for the treatment of T-cell malignancies and other cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Wugen Comps
Public and private peers based on sector, stage, and business model.
Wugen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Aug 27, 2025 | ||||
| Series B | Jul 15, 2021 |
Key People
Founding team and executive leadership
Wugen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LYZZ Capital | Series B, Early Funding, Series A |
| Intermediate Capital Group | Early Funding, Series B |
| Fidelity Management & Research Company | Series B, Early Funding |
| Tybourne Capital Management | Early Funding, Series B |
| RiverVest Venture Partners | Series B, Early Funding, Series A |
| Abingworth | Early Funding, Series B |
| Alexandria Venture Investments | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2025
$115M raised in early funding.
- Feb 26, 2025
Jim Faulkner appointed as interim CTO.
Wugen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Wugen's valuation, stock price, and market status.
